COMMUNIQUÉS West-GlobeNewswire

ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model
21/02/2024
Clinical Validation of the Brain Model Published Online in the Journal NeuroImage SOLANA BEACH, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and [...]
NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders
21/02/2024
LANGHORNE, Pa., Feb. 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]
UFC Phenom Marlon “Chito” Vera Dives Into The World of Infused Beverages With MAISON BLOOM
21/02/2024
Vera Joins the Leader in Premium MALTernative TM Beverages and Embraces Drinking Different SAN FRANCISCO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- via IBN – Marlon "Chito" Vera, renowned UFC fighter and entrepreneur, has taken [...]
BioCryst to Present at Upcoming Investor Conferences
21/02/2024
RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the TD Cowen 44 th Annual Health Care Conference in Boston [...]
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
21/02/2024
HAMILTON, Bermuda, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Wednesday, February 28, 2024 at 8:30 a.m. Eastern [...]
Teknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
21/02/2024
HOLLISTER, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]
HealthEquity Reports Year-End Sales Metrics
21/02/2024
Provides Business Outlook, Investor Day Information DRAPER, Utah, Feb. 21, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA [...]
Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation
21/02/2024
Baxter to act as exclusive partner to Spectral for 10 years following PMX approval by U.S. FDA TORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage [...]
Un meilleur accès aux soins et une expertise en matière de chaîne du froid renforcée pour Fortrea avec le développement de FortreaRx™
21/02/2024
Le redimensionnement de la pharmacie spécialisée non commerciale de Fortrea apporte des solutions flexibles et évolutives à ses clients, et permet de délivrer des médicaments révolutionnaires directement aux patients [...]
MEDIA RELEASE: The Ford government is starving local public hospitals to privatize them, charge health advocates
21/02/2024
TORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- A new report, Robbing from the public to build the private: The Ford government’s hospital privatization scheme reveals that local hospitals in every region of Ontario have [...]
Spinal Rehab & Sports Medicine Announces Dr. Bob Meyer's 25-Year Anniversary in Sports Medicine
21/02/2024
AUSTIN, Texas, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Spinal Rehab & Sports Medicine proudly announces Dr. Bob Meyer, D.C. unparalleled expertise in sports medicine, serving the vibrant community of Austin, TX, for over [...]
InkSpace Imaging Announces a Strategic Distribution Partnership with American Medical Imaging
21/02/2024
PLEASANTON, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- InkSpace Imaging announced a strategic distribution partnership with American Medical Imaging (AMI) , a leading US distributor of medical imaging equipment. This [...]
AdhereTech Announces Appointment of Paul Sekhri to Board of Directors
21/02/2024
Life sciences industry veteran brings strong strategic and operational expertise SUMMIT, N.J., Feb. 21, 2024 (GLOBE NEWSWIRE) -- AdhereTech, Inc., the market leading provider of real-time medication adherence solutions [...]
RS BioTherapeutics Creates Therapeutic Expert Council to Provide Guidance on Development of First-in-Class Agent Focused on Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
21/02/2024
RS BioTherapeutics’ Therapeutic Expert Council consists of globally renowned pulmonary experts CUMBERLAND, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines [...]
DepYmed to Meet with Investors at the BIO CEO and Investor Conference
21/02/2024
FARMINGDALE, N.Y., Feb. 21, 2024 (GLOBE NEWSWIRE) -- DepYmed, Inc. (“DepYmed” or the “Company”) is a preclinical stage pharmaceutical company focused on developing transformative treatments for rare diseases and [...]
Immix Biopharma 12 Month Review Progress Update
21/02/2024
LOS ANGELES, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced its 12-month progress [...]
PharmaTher’s Sairiyo Therapeutics Inc. Advances Clinical Development of Patented Reformulated Cepharanthine for Phase 1 Study in Australia
21/02/2024
TORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, announced today Sairiyo Therapeutics Inc. (“Sairiyo”), [...]
Lytus Technologies Holdings PTV. Ltd. announces 1 for 60 Reverse Stock Split
21/02/2024
Dubai, UAE, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Lytus Technologies Holdings PTV. Ltd. (the “Company”) (Nasdaq:LYT), a leading global technology-driven services company, today announced that on February 5 th , 2024, the [...]
Notice for the Annual General Meeting of Novo Nordisk A/S
21/02/2024
Bagsværd, Denmark, 21 February 2024 – The Annual General Meeting of Novo Nordisk A/S will be held on: Thursday 21 March 2024 at 14.00 (CET) The Annual General Meeting is held as a partially electronic general meeting. [...]

Pages